Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Slowing Down Stock
1078.2000 20.00 (1.89%)
NSE Aug 13, 2025 15:31 PM
Volume: 444.4K
 

1078.20
1.89%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. has lost -26.24% in the last 1 Year
More from Aurobindo Pharma Ltd.
Recommended